IS7703A - Aðferð til að framleiða solmítriptanefnasambönd - Google Patents
Aðferð til að framleiða solmítriptanefnasamböndInfo
- Publication number
- IS7703A IS7703A IS7703A IS7703A IS7703A IS 7703 A IS7703 A IS 7703A IS 7703 A IS7703 A IS 7703A IS 7703 A IS7703 A IS 7703A IS 7703 A IS7703 A IS 7703A
- Authority
- IS
- Iceland
- Prior art keywords
- give
- viii
- compound
- pyranoindolone
- hydrazone
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
- MMCPOSDMTGQNKG-UHFFFAOYSA-N anilinium chloride Chemical compound Cl.NC1=CC=CC=C1 MMCPOSDMTGQNKG-UHFFFAOYSA-N 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 150000007857 hydrazones Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- HCUARRIEZVDMPT-UHFFFAOYSA-M 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)[O-])=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-M 0.000 abstract 1
- 238000006783 Fischer indole synthesis reaction Methods 0.000 abstract 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000012954 diazonium Substances 0.000 abstract 1
- 150000001989 diazonium salts Chemical class 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- OLYUSKJHJHSMGA-UHFFFAOYSA-N oxane-2,3-dione Chemical compound O=C1CCCOC1=O OLYUSKJHJHSMGA-UHFFFAOYSA-N 0.000 abstract 1
- 230000020477 pH reduction Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- UTAZCRNOSWWEFR-ZDUSSCGKSA-N zolmitriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1C[C@H]1COC(=O)N1 UTAZCRNOSWWEFR-ZDUSSCGKSA-N 0.000 abstract 1
- 229960001360 zolmitriptan Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200201873A ES2204302B2 (es) | 2002-08-07 | 2002-08-07 | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| PCT/IB2003/003536 WO2004014901A1 (en) | 2002-08-07 | 2003-08-05 | Process for preparing zolmitriptan compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS7703A true IS7703A (is) | 2005-02-21 |
| IS2333B IS2333B (is) | 2008-02-15 |
Family
ID=31502893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7703A IS2333B (is) | 2002-08-07 | 2005-02-21 | Aðferð til að framleiða zolmítriptanefnasambönd |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7342035B2 (is) |
| EP (1) | EP1534705B1 (is) |
| KR (1) | KR100753353B1 (is) |
| AT (1) | ATE334126T1 (is) |
| AU (1) | AU2003250476A1 (is) |
| DE (1) | DE60307109T2 (is) |
| ES (2) | ES2204302B2 (is) |
| IS (1) | IS2333B (is) |
| NO (1) | NO20051178L (is) |
| TW (1) | TW200404059A (is) |
| WO (1) | WO2004014901A1 (is) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2204302B2 (es) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| US20070173536A1 (en) * | 2004-02-06 | 2007-07-26 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of zolmitriptan |
| US20050245585A1 (en) * | 2004-04-22 | 2005-11-03 | Islam Aminul | Process for preparing optically pure zolmitriptan |
| EP1799675A4 (en) * | 2004-04-22 | 2010-04-28 | Reddys Lab Ltd Dr | PROCESS FOR THE PRODUCTION OF OPTICALLY PURE ZOLMITRIPTAN |
| EP1812428A2 (en) * | 2004-11-19 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | Zolmitriptan crystal forms |
| ES2270717B1 (es) * | 2005-08-08 | 2008-03-01 | Ragactives, S.L. | Procedimiento para la obtencion de derivados de triptamina. |
| ATE510836T1 (de) * | 2006-01-19 | 2011-06-15 | Matrix Lab Ltd | Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin |
| NZ584971A (en) | 2007-10-03 | 2012-06-29 | Generics Uk Ltd | Process for the preparation of zolmitriptan, salts and solvates thereof |
| US8343381B1 (en) | 2008-05-16 | 2013-01-01 | E I Du Pont De Nemours And Company | Hole transport composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT97888B (pt) * | 1990-06-07 | 1998-12-31 | Zeneca Ltd | Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem |
| EP0532634A1 (en) * | 1990-06-07 | 1993-03-24 | Smithkline Beecham Corporation | Phthalamic acids and their isomers for treating leukotriene-related diseases |
| GB9516145D0 (en) * | 1995-08-07 | 1995-10-04 | Wellcome Found | Improved chemical synthesis |
| US5998438A (en) * | 1996-11-26 | 1999-12-07 | Allelix Biopharmaceuticals, Inc. | 5-cyclo indole compounds |
| ES2204302B2 (es) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| ES2204303B2 (es) * | 2002-08-07 | 2004-12-16 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
-
2002
- 2002-08-07 ES ES200201873A patent/ES2204302B2/es not_active Expired - Fee Related
-
2003
- 2003-08-05 KR KR1020057002093A patent/KR100753353B1/ko not_active Expired - Fee Related
- 2003-08-05 WO PCT/IB2003/003536 patent/WO2004014901A1/en not_active Ceased
- 2003-08-05 AT AT03784403T patent/ATE334126T1/de not_active IP Right Cessation
- 2003-08-05 AU AU2003250476A patent/AU2003250476A1/en not_active Abandoned
- 2003-08-05 EP EP03784403A patent/EP1534705B1/en not_active Expired - Lifetime
- 2003-08-05 ES ES03784403T patent/ES2270144T3/es not_active Expired - Lifetime
- 2003-08-05 DE DE60307109T patent/DE60307109T2/de not_active Expired - Fee Related
- 2003-08-05 US US10/527,127 patent/US7342035B2/en not_active Expired - Lifetime
- 2003-08-05 TW TW092121366A patent/TW200404059A/zh unknown
-
2005
- 2005-02-21 IS IS7703A patent/IS2333B/is unknown
- 2005-03-04 NO NO20051178A patent/NO20051178L/no not_active Application Discontinuation
-
2007
- 2007-11-15 US US11/940,363 patent/US7563904B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003250476A1 (en) | 2004-02-25 |
| TW200404059A (en) | 2004-03-16 |
| WO2004014901A1 (en) | 2004-02-19 |
| DE60307109D1 (de) | 2006-09-07 |
| IS2333B (is) | 2008-02-15 |
| ES2204302B2 (es) | 2005-03-01 |
| ATE334126T1 (de) | 2006-08-15 |
| EP1534705B1 (en) | 2006-07-26 |
| US7563904B2 (en) | 2009-07-21 |
| DE60307109T2 (de) | 2007-02-15 |
| ES2204302A1 (es) | 2004-04-16 |
| KR20050060061A (ko) | 2005-06-21 |
| US7342035B2 (en) | 2008-03-11 |
| ES2270144T3 (es) | 2007-04-01 |
| US20060025600A1 (en) | 2006-02-02 |
| KR100753353B1 (ko) | 2007-08-30 |
| NO20051178L (no) | 2005-03-04 |
| EP1534705A1 (en) | 2005-06-01 |
| US20080306279A1 (en) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112283T1 (el) | Μεθοδος για την παρασκευη 17-βινυλ-τριφλικων ως ενδιaμεσα | |
| PY0713342A (es) | Uso de bifenilamidas de acido arilcarboxílico para el tratamiento de semillas | |
| WO2006027705A3 (en) | Synthesis of triethylenetetramines | |
| IS7703A (is) | Aðferð til að framleiða solmítriptanefnasambönd | |
| NO20072930L (no) | Tripentylcitrater og deres anvendelse | |
| DK1856045T3 (da) | 1-eddikesyreindolderviater med PGD2-antagonisteffekt | |
| TW200626580A (en) | Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester | |
| SG187400A1 (en) | (aza)indole derivative substituted in position 5,pharmaceutical composition comprising it, intermediate compounds and preparation process therefor | |
| NO20051155L (no) | Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse | |
| ECSP077167A (es) | Nuevos compuestos heterociclicos | |
| DE602005008402D1 (de) | Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole | |
| NO20080165L (no) | Alfa-(aryl-OR heteroaryl-metyl)-beta piperidinopropanamidforbindelser som ORL1-receptorantagonister | |
| NO20071253L (no) | Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer. | |
| BRPI0415002A (pt) | processo para preparação de compostos heterocìclicos n-amino substituìdos | |
| WO2009039362A3 (en) | Chiral synthesis of diazepinoquinolines | |
| MX2007007725A (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina (amida, sulfonamida, carbamato y urea), como antagonistas de los receptores cb1 de los cannabinoides. | |
| BR112012021749B1 (pt) | processos para a preparação de um composto e composto benzilamina | |
| US20090209648A1 (en) | Phenylacetic Acid Derivatives | |
| DK1877370T3 (da) | Fremgangsmåde til fremstilling af hydrazon-derivater | |
| WO2008056378A3 (en) | Novel process for the preparation of naratriptan hydrochloride | |
| ATE489961T1 (de) | Par-2-antagonisten | |
| DE60306636D1 (de) | Wachstumhormonsekretionsförderer | |
| DK1140793T3 (da) | Fremgangsmåde til syntese af 1-(aminomethyl)cyclohexyl-eddikesyre | |
| CY1116177T1 (el) | Μεθοδος για την παρασκευη 17-βινυλο-τριφλικων ως ενδιαμεσα | |
| ES2270717B1 (es) | Procedimiento para la obtencion de derivados de triptamina. |